Annual EBIT
$569.90 M
-$137.10 M-19.39%
December 31, 2024
Summary
- As of February 26, 2025, WST annual earnings before interest & taxes is $569.90 million, with the most recent change of -$137.10 million (-19.39%) on December 31, 2024.
- During the last 3 years, WST annual EBIT has fallen by -$187.20 million (-24.73%).
- WST annual EBIT is now -24.73% below its all-time high of $757.10 million, reached on December 31, 2021.
Performance
WST EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$159.60 M
-$5.60 M-3.39%
December 1, 2024
Summary
- As of February 26, 2025, WST quarterly earnings before interest & taxes is $159.60 million, with the most recent change of -$5.60 million (-3.39%) on December 1, 2024.
- Over the past year, WST quarterly EBIT has dropped by -$9.80 million (-5.79%).
- WST quarterly EBIT is now -30.31% below its all-time high of $229.00 million, reached on June 30, 2022.
Performance
WST Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$584.00 M
-$9.80 M-1.65%
December 1, 2024
Summary
- As of February 26, 2025, WST TTM earnings before interest & taxes is $584.00 million, with the most recent change of -$9.80 million (-1.65%) on December 1, 2024.
- Over the past year, WST TTM EBIT has dropped by -$123.00 million (-17.40%).
- WST TTM EBIT is now -25.74% below its all-time high of $786.40 million, reached on June 30, 2022.
Performance
WST TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
WST EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.4% | -5.8% | -17.4% |
| 3 y3 years | -24.7% | -5.8% | -17.4% |
| 5 y5 years | +89.8% | -5.8% | -17.4% |
WST EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.7% | at low | -30.3% | +23.7% | -25.7% | at low |
| 5 y | 5-year | -24.7% | +89.8% | -30.3% | +100.8% | -25.7% | +94.5% |
| alltime | all time | -24.7% | >+9999.0% | -30.3% | +182.7% | -25.7% | +439.7% |
West Pharmaceutical Services EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $569.90 M(-19.4%) | - | - |
| Dec 2024 | - | $159.60 M(-3.4%) | $584.00 M(-1.7%) |
| Sep 2024 | - | $165.20 M(+26.9%) | $593.80 M(-4.0%) |
| Jun 2024 | - | $130.20 M(+0.9%) | $618.50 M(-8.5%) |
| Mar 2024 | - | $129.00 M(-23.8%) | $675.90 M(-4.4%) |
| Dec 2023 | $707.00 M(+2.8%) | $169.40 M(-10.8%) | $707.00 M(+5.8%) |
| Sep 2023 | - | $189.90 M(+1.2%) | $668.00 M(+8.4%) |
| Jun 2023 | - | $187.60 M(+17.2%) | $616.50 M(-6.3%) |
| Mar 2023 | - | $160.10 M(+22.8%) | $657.90 M(-4.3%) |
| Dec 2022 | $687.80 M(-9.2%) | $130.40 M(-5.8%) | $687.80 M(-7.3%) |
| Sep 2022 | - | $138.40 M(-39.6%) | $741.90 M(-5.7%) |
| Jun 2022 | - | $229.00 M(+20.5%) | $786.40 M(+2.1%) |
| Mar 2022 | - | $190.00 M(+3.0%) | $770.30 M(+1.7%) |
| Dec 2021 | $757.10 M(+84.9%) | $184.50 M(+0.9%) | $757.10 M(+9.8%) |
| Sep 2021 | - | $182.90 M(-14.1%) | $689.80 M(+13.7%) |
| Jun 2021 | - | $212.90 M(+20.4%) | $606.70 M(+21.9%) |
| Mar 2021 | - | $176.80 M(+50.9%) | $497.80 M(+21.6%) |
| Dec 2020 | $409.50 M(+36.4%) | $117.20 M(+17.4%) | $409.50 M(+10.1%) |
| Sep 2020 | - | $99.80 M(-4.0%) | $371.80 M(+9.7%) |
| Jun 2020 | - | $104.00 M(+17.5%) | $339.00 M(+7.1%) |
| Mar 2020 | - | $88.50 M(+11.3%) | $316.60 M(+5.4%) |
| Dec 2019 | $300.30 M(+20.6%) | $79.50 M(+18.7%) | $300.30 M(+3.9%) |
| Sep 2019 | - | $67.00 M(-17.9%) | $288.90 M(+1.4%) |
| Jun 2019 | - | $81.60 M(+13.0%) | $285.00 M(+7.3%) |
| Mar 2019 | - | $72.20 M(+6.0%) | $265.70 M(+6.7%) |
| Dec 2018 | $249.10 M(+8.2%) | $68.10 M(+7.9%) | $249.10 M(+2.8%) |
| Sep 2018 | - | $63.10 M(+1.3%) | $242.40 M(-0.5%) |
| Jun 2018 | - | $62.30 M(+12.1%) | $243.60 M(+8.7%) |
| Mar 2018 | - | $55.60 M(-9.4%) | $224.20 M(-2.6%) |
| Dec 2017 | $230.20 M(+16.3%) | $61.40 M(-4.5%) | $230.20 M(+3.0%) |
| Sep 2017 | - | $64.30 M(+49.9%) | $223.40 M(+6.1%) |
| Jun 2017 | - | $42.90 M(-30.4%) | $210.60 M(-8.1%) |
| Mar 2017 | - | $61.60 M(+12.8%) | $229.20 M(+15.8%) |
| Dec 2016 | $197.90 M(+52.0%) | $54.60 M(+6.0%) | $197.90 M(+4.8%) |
| Sep 2016 | - | $51.50 M(-16.3%) | $188.80 M(+40.6%) |
| Jun 2016 | - | $61.50 M(+103.0%) | $134.30 M(+19.6%) |
| Mar 2016 | - | $30.30 M(-33.4%) | $112.30 M(-13.7%) |
| Dec 2015 | $130.20 M(-29.8%) | $45.50 M(-1616.7%) | $130.20 M(+0.1%) |
| Sep 2015 | - | -$3.00 M(-107.6%) | $130.10 M(-27.3%) |
| Jun 2015 | - | $39.50 M(-18.0%) | $178.90 M(-7.8%) |
| Mar 2015 | - | $48.20 M(+6.2%) | $194.00 M(+4.6%) |
| Dec 2014 | $185.50 M(+13.0%) | $45.40 M(-0.9%) | $185.50 M(+4.5%) |
| Sep 2014 | - | $45.80 M(-16.1%) | $177.50 M(+3.3%) |
| Jun 2014 | - | $54.60 M(+37.5%) | $171.80 M(+7.3%) |
| Mar 2014 | - | $39.70 M(+6.1%) | $160.10 M(-2.4%) |
| Dec 2013 | $164.10 M(+31.0%) | $37.40 M(-6.7%) | $164.10 M(+3.5%) |
| Sep 2013 | - | $40.10 M(-6.5%) | $158.50 M(+9.2%) |
| Jun 2013 | - | $42.90 M(-1.8%) | $145.20 M(+14.4%) |
| Mar 2013 | - | $43.70 M(+37.4%) | $126.90 M(+1.3%) |
| Dec 2012 | $125.30 M(+13.0%) | $31.80 M(+18.7%) | $125.30 M(+3.6%) |
| Sep 2012 | - | $26.80 M(+8.9%) | $120.90 M(+0.2%) |
| Jun 2012 | - | $24.60 M(-41.6%) | $120.60 M(-2.8%) |
| Mar 2012 | - | $42.10 M(+53.6%) | $124.10 M(+11.8%) |
| Dec 2011 | $110.90 M(+21.5%) | $27.40 M(+3.4%) | $111.00 M(+23.6%) |
| Sep 2011 | - | $26.50 M(-5.7%) | $89.80 M(+1.2%) |
| Jun 2011 | - | $28.10 M(-3.1%) | $88.70 M(+134.7%) |
| Mar 2011 | - | $29.00 M(+367.7%) | $37.80 M(0.0%) |
| Dec 2010 | $91.30 M(-7.1%) | $6.20 M(-75.6%) | $37.80 M(-29.3%) |
| Sep 2010 | - | $25.40 M(-211.4%) | $53.50 M(-1.5%) |
| Jun 2010 | - | -$22.80 M(-178.6%) | $54.30 M(-48.7%) |
| Mar 2010 | - | $29.00 M(+32.4%) | $105.90 M(+7.6%) |
| Dec 2009 | $98.30 M(-21.7%) | $21.90 M(-16.4%) | $98.40 M(-3.0%) |
| Sep 2009 | - | $26.20 M(-9.0%) | $101.40 M(+8.4%) |
| Jun 2009 | - | $28.80 M(+34.0%) | $93.50 M(-13.4%) |
| Mar 2009 | - | $21.50 M(-13.7%) | $108.00 M(-14.0%) |
| Dec 2008 | $125.50 M(+24.4%) | $24.90 M(+36.1%) | $125.60 M(+9.9%) |
| Sep 2008 | - | $18.30 M(-57.7%) | $114.30 M(+5.0%) |
| Jun 2008 | - | $43.30 M(+10.7%) | $108.90 M(+8.4%) |
| Mar 2008 | - | $39.10 M(+187.5%) | $100.50 M(-0.5%) |
| Dec 2007 | $100.90 M(-4.7%) | $13.60 M(+5.4%) | $101.00 M(-10.9%) |
| Sep 2007 | - | $12.90 M(-63.0%) | $113.30 M(-5.7%) |
| Jun 2007 | - | $34.90 M(-11.9%) | $120.10 M(+2.4%) |
| Mar 2007 | - | $39.60 M(+52.9%) | $117.30 M(+10.8%) |
| Dec 2006 | $105.90 M(+44.1%) | $25.90 M(+31.5%) | $105.90 M(+4.0%) |
| Sep 2006 | - | $19.70 M(-38.6%) | $101.80 M(+6.9%) |
| Jun 2006 | - | $32.10 M(+13.8%) | $95.20 M(+16.7%) |
| Mar 2006 | - | $28.20 M(+29.4%) | $81.60 M(+11.0%) |
| Dec 2005 | $73.50 M(+45.8%) | $21.80 M(+66.4%) | $73.50 M(+17.2%) |
| Sep 2005 | - | $13.10 M(-29.2%) | $62.70 M(+5.2%) |
| Jun 2005 | - | $18.50 M(-8.0%) | $59.60 M(+4.7%) |
| Mar 2005 | - | $20.10 M(+82.7%) | $56.90 M(+12.9%) |
| Dec 2004 | $50.40 M | $11.00 M(+10.0%) | $50.40 M(-46.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2004 | - | $10.00 M(-36.7%) | $94.20 M(+3.4%) |
| Jun 2004 | - | $15.80 M(+16.2%) | $91.10 M(+5.8%) |
| Mar 2004 | - | $13.60 M(-75.2%) | $86.10 M(+9.0%) |
| Dec 2003 | $79.00 M(+53.1%) | $54.80 M(+694.2%) | $79.00 M(+68.4%) |
| Sep 2003 | - | $6.90 M(-36.1%) | $46.90 M(+0.2%) |
| Jun 2003 | - | $10.80 M(+66.2%) | $46.80 M(+2.2%) |
| Mar 2003 | - | $6.50 M(-71.4%) | $45.80 M(-11.9%) |
| Dec 2002 | $51.60 M(+20.6%) | $22.70 M(+233.8%) | $52.00 M(+34.7%) |
| Sep 2002 | - | $6.80 M(-30.6%) | $38.60 M(-5.9%) |
| Jun 2002 | - | $9.80 M(-22.8%) | $41.00 M(-3.3%) |
| Mar 2002 | - | $12.70 M(+36.6%) | $42.40 M(+3.7%) |
| Dec 2001 | $42.80 M(-6.3%) | $9.30 M(+1.1%) | $40.90 M(-13.7%) |
| Sep 2001 | - | $9.20 M(-17.9%) | $47.40 M(+1.9%) |
| Jun 2001 | - | $11.20 M(0.0%) | $46.50 M(0.0%) |
| Mar 2001 | - | $11.20 M(-29.1%) | $46.50 M(+0.9%) |
| Dec 2000 | $45.70 M(-31.2%) | $15.80 M(+90.4%) | $46.10 M(+4.5%) |
| Sep 2000 | - | $8.30 M(-25.9%) | $44.10 M(-13.4%) |
| Jun 2000 | - | $11.20 M(+3.7%) | $50.90 M(-14.9%) |
| Mar 2000 | - | $10.80 M(-21.7%) | $59.80 M(-9.9%) |
| Dec 1999 | $66.40 M(+2.6%) | $13.80 M(-8.6%) | $66.40 M(-32.6%) |
| Sep 1999 | - | $15.10 M(-24.9%) | $98.50 M(-1.0%) |
| Jun 1999 | - | $20.10 M(+15.5%) | $99.50 M(+3.9%) |
| Mar 1999 | - | $17.40 M(-62.1%) | $95.80 M(+48.1%) |
| Dec 1998 | $64.70 M(+4.5%) | $45.90 M(+185.1%) | $64.70 M(+80.2%) |
| Sep 1998 | - | $16.10 M(-1.8%) | $35.90 M(+10.5%) |
| Jun 1998 | - | $16.40 M(-219.7%) | $32.50 M(-2.4%) |
| Mar 1998 | - | -$13.70 M(-180.1%) | $33.30 M(-46.0%) |
| Dec 1997 | $61.90 M(+16.1%) | $17.10 M(+34.6%) | $61.70 M(+2.2%) |
| Sep 1997 | - | $12.70 M(-26.2%) | $60.40 M(+2.0%) |
| Jun 1997 | - | $17.20 M(+17.0%) | $59.20 M(+6.1%) |
| Mar 1997 | - | $14.70 M(-7.0%) | $55.80 M(+4.7%) |
| Dec 1996 | $53.30 M(+10.4%) | $15.80 M(+37.4%) | $53.30 M(+9.7%) |
| Sep 1996 | - | $11.50 M(-16.7%) | $48.60 M(+7.5%) |
| Jun 1996 | - | $13.80 M(+13.1%) | $45.20 M(0.0%) |
| Mar 1996 | - | $12.20 M(+9.9%) | $45.20 M(-6.4%) |
| Dec 1995 | $48.30 M(+2.5%) | $11.10 M(+37.0%) | $48.30 M(+0.2%) |
| Sep 1995 | - | $8.10 M(-41.3%) | $48.20 M(-3.4%) |
| Jun 1995 | - | $13.80 M(-9.8%) | $49.90 M(+1.8%) |
| Mar 1995 | - | $15.30 M(+39.1%) | $49.00 M(+4.0%) |
| Dec 1994 | $47.10 M(+14.6%) | $11.00 M(+12.2%) | $47.10 M(-1.7%) |
| Sep 1994 | - | $9.80 M(-24.0%) | $47.90 M(+1.7%) |
| Jun 1994 | - | $12.90 M(-3.7%) | $47.10 M(+4.0%) |
| Mar 1994 | - | $13.40 M(+13.6%) | $45.30 M(+10.2%) |
| Dec 1993 | $41.10 M(+3.5%) | $11.80 M(+31.1%) | $41.10 M(+9.6%) |
| Sep 1993 | - | $9.00 M(-18.9%) | $37.50 M(+3.0%) |
| Jun 1993 | - | $11.10 M(+20.7%) | $36.40 M(-2.2%) |
| Mar 1993 | - | $9.20 M(+12.2%) | $37.20 M(-5.6%) |
| Dec 1992 | $39.70 M(-3153.8%) | $8.20 M(+3.8%) | $39.40 M(+567.8%) |
| Sep 1992 | - | $7.90 M(-33.6%) | $5.90 M(+7.3%) |
| Jun 1992 | - | $11.90 M(+4.4%) | $5.50 M(+323.1%) |
| Mar 1992 | - | $11.40 M(-145.1%) | $1.30 M(-208.3%) |
| Dec 1991 | -$1.30 M(-106.1%) | -$25.30 M(-437.3%) | -$1.20 M(-104.9%) |
| Sep 1991 | - | $7.50 M(-2.6%) | $24.60 M(+7.9%) |
| Jun 1991 | - | $7.70 M(-13.5%) | $22.80 M(+9.1%) |
| Mar 1991 | - | $8.90 M(+1680.0%) | $20.90 M(-2.8%) |
| Dec 1990 | $21.20 M(-41.3%) | $500.00 K(-91.2%) | $21.50 M(-112.5%) |
| Sep 1990 | - | $5.70 M(-1.7%) | -$171.90 M(+58.9%) |
| Jun 1990 | - | $5.80 M(-38.9%) | -$108.20 M(+213.6%) |
| Mar 1990 | - | $9.50 M(-104.9%) | -$34.50 M(-195.6%) |
| Dec 1989 | $36.10 M(+18.8%) | -$192.90 M(-378.0%) | $36.10 M(-22.5%) |
| Sep 1989 | - | $69.40 M(-12.7%) | $46.60 M(+0.9%) |
| Jun 1989 | - | $79.50 M(-0.7%) | $46.20 M(+12.1%) |
| Mar 1989 | - | $80.10 M(-143.9%) | $41.20 M(+35.5%) |
| Dec 1988 | $30.40 M(+1.7%) | -$182.40 M(-364.3%) | $30.40 M(-45.6%) |
| Sep 1988 | - | $69.00 M(-7.4%) | $55.90 M(+27.3%) |
| Jun 1988 | - | $74.50 M(+7.5%) | $43.90 M(+17.7%) |
| Mar 1988 | - | $69.30 M(-144.2%) | $37.30 M(+24.7%) |
| Dec 1987 | $29.90 M(-2.9%) | -$156.90 M(-375.3%) | $29.90 M(-30.6%) |
| Sep 1987 | - | $57.00 M(-16.1%) | $43.10 M(0.0%) |
| Jun 1987 | - | $67.90 M(+9.7%) | $43.10 M(+9.1%) |
| Mar 1987 | - | $61.90 M(-143.1%) | $39.50 M(+28.2%) |
| Dec 1986 | $30.80 M(+31.1%) | -$143.70 M(-352.1%) | $30.80 M(-44.6%) |
| Sep 1986 | - | $57.00 M(-11.4%) | $55.60 M(+34.6%) |
| Jun 1986 | - | $64.30 M(+20.9%) | $41.30 M(+50.7%) |
| Mar 1986 | - | $53.20 M(-144.7%) | $27.40 M(+16.1%) |
| Dec 1985 | $23.50 M(+14.1%) | -$118.90 M(-378.5%) | $23.60 M(-4.1%) |
| Sep 1985 | - | $42.70 M(-15.3%) | $24.60 M(-0.4%) |
| Jun 1985 | - | $50.40 M(+2.0%) | $24.70 M(+11.3%) |
| Mar 1985 | - | $49.40 M(-141.9%) | $22.20 M(+7.8%) |
| Dec 1984 | $20.60 M | -$117.90 M(-375.5%) | $20.60 M(-85.1%) |
| Sep 1984 | - | $42.80 M(-10.6%) | $138.50 M(+44.7%) |
| Jun 1984 | - | $47.90 M(+0.2%) | $95.70 M(+100.2%) |
| Mar 1984 | - | $47.80 M | $47.80 M |
FAQ
- What is West Pharmaceutical Services annual earnings before interest & taxes?
- What is the all time high annual EBIT for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual EBIT year-on-year change?
- What is West Pharmaceutical Services quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly EBIT year-on-year change?
- What is West Pharmaceutical Services TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM EBIT year-on-year change?
What is West Pharmaceutical Services annual earnings before interest & taxes?
The current annual EBIT of WST is $569.90 M
What is the all time high annual EBIT for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual earnings before interest & taxes is $757.10 M
What is West Pharmaceutical Services annual EBIT year-on-year change?
Over the past year, WST annual earnings before interest & taxes has changed by -$137.10 M (-19.39%)
What is West Pharmaceutical Services quarterly earnings before interest & taxes?
The current quarterly EBIT of WST is $159.60 M
What is the all time high quarterly EBIT for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly earnings before interest & taxes is $229.00 M
What is West Pharmaceutical Services quarterly EBIT year-on-year change?
Over the past year, WST quarterly earnings before interest & taxes has changed by -$9.80 M (-5.79%)
What is West Pharmaceutical Services TTM earnings before interest & taxes?
The current TTM EBIT of WST is $584.00 M
What is the all time high TTM EBIT for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM earnings before interest & taxes is $786.40 M
What is West Pharmaceutical Services TTM EBIT year-on-year change?
Over the past year, WST TTM earnings before interest & taxes has changed by -$123.00 M (-17.40%)